Blauvelt A, Reich K, Lebwohl M, Burge D, Arendt C, Peterson L, Rolleri R, Gottlieb A. Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials. J of Skin [Internet]. 2018Feb.23 [cited 2024Jul.3];2(S1):S3. Available from: https://jofskin.org/index.php/skin/article/view/306